For the Inventor, By the Inventor

Enter assignee name

Devon, PA, United States of America

Zynerba Pharmaceuticals, Inc.

USPTO Granted Patents = 13

CIPO Patents = 32

EPO Patents = 8

Trademarks = 4

Forward Citations = 155

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Donna Gutterman (8 out of 11 patents)

Terri Sebree (8 out of 24 patents)

Marcel Bonn-Miller (7 out of 9 patents)

4. Nancy Tich (5 out of 5 patents)

5. John Messenheimer (5 out of 6 patents)

6. Miroslaw Jerzy Golinski (5 out of 25 patents)

7. Dana Carmel Hammell (4 out of 10 patents)

8. Audra Lynn Stinchcomb (4 out of 20 patents)

9. Jeffrey Lynn Howard (3 out of 6 patents)

10. Jeffery Lynn Howard (2 out of 4 patents)

11. Stan Lee Banks (2 out of 6 patents)

12. Audra Lynn Strinchcomb (1 out of 1 patent)

13. Dana Carmel Hammel (1 out of 1 patent)

14. Guohua Li (1 patent)

15. Jeffry Lynn Howard (0 patent)

13 patents: Sort by Forward Citations

1. 11779549 - Treatment of Fragile X Syndrome with cannabidiol (2023-10-10),

2. 11458110 - Treatment of Fragile X Syndrome with cannabidiol (2022-10-04),

3. 11458109 - Treatment of 22Q11.2 deletion syndrome with cannabidiol (2022-10-04),

4. 10758497 - Treatment of fragile x syndrome with cannabidiol (2020-09-01),

5. RE47885 - Use of cannabidiol prodrugs in pharmaceutical compositions (2020-03-02),

6. 10568848 - Treatment of autism with cannabidiol (2020-02-25),

7. 10471022 - Treatment of fragile X syndrome with cannabidiol (2019-11-12),

8. 10314792 - Treatment of autism with cannabidiol (2019-06-11),

9. 10213390 - Treatment of fragile X syndrome with cannabidiol (2019-02-26),

10. 9957246 - Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same (2018-05-01),

11. 9695143 - Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same (2017-07-04),

12. 9533942 - Use of cannabidiol prodrugs in topical and transdermal administration with microneedles (2017-01-03),

13. 8980942 - Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same (2015-03-17),

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid-based medicines. Their mission is to improve the lives of patients with rare and near-rare neurological and psychiatric disorders. Zynerba is committed to leveraging the therapeutic potential of cannabinoids to address unmet medical needs. Through rigorous scientific research and development, they aim to provide safe and effective treatments to those who need them.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

13 Patents

#1 in Devon, PA

#841 in Pennsylvania

#23,090 in US

#43,583 in the World

Devon, PA, United States of America

Zynerba Pharmaceuticals, Inc.

Forward Citations = 155

34 inventors:

Donna Gutterman (8 out of 11 patents)

Terri Sebree (8 out of 24 patents)

Marcel Bonn-Miller (7 out of 9 patents)

4. Nancy Tich (5 out of 5 patents)

5. John Messenheimer (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…